Article | REF: MED5050 V1

Fate of nanoparticles used as drugs in the body

Author: Frédéric LAGARCE

Publication date: October 10, 2014

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


Français

2. Fate of nanomedicines after intravenous administration

2.1 Pharmacokinetics of nanoparticles

After blood administration, nanoparticles circulate in the circulatory torrent. To reach the tissues, these carriers will have to pass through arteries and then smaller-diameter arterioles. Thus, a dose of nanoparticles administered into a vein will reach the heart via the vena cava, then necessarily pass through the lungs to return to the heart via the pulmonary vein and rejoin the arterial circulation via the aorta (figure 2 ). Passage through the lungs is not a problem for small...

You do not have access to this resource.

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


The Ultimate Scientific and Technical Reference

A Comprehensive Knowledge Base, with over 1,200 authors and 100 scientific advisors
+ More than 10,000 articles and 1,000 how-to sheets, over 800 new or updated articles every year
From design to prototyping, right through to industrialization, the reference for securing the development of your industrial projects

This article is included in

Healthcare technologies

This offer includes:

Knowledge Base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

Practical Path

Operational and didactic, to guarantee the acquisition of transversal skills

Doc & Quiz

Interactive articles with quizzes, for constructive reading

Subscribe now!

Ongoing reading
Fate of nanomedicines after intravenous administration